For TEVA - modifying my model to their case, Revenue $450M annual, keeping same COGS and distribution costs, I get profit in the range of $140M-160M annually.
Still substantial, abnormally profitable for a generic and worth a fight, IMO.
ij
There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)